Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Private equity investments scare pharma clients, says CRO

16-Apr-2014 - Pharmaceutical clients view contract research organisations (CROs) with private equity investments as unstable and more focused on financial growth than their operations, according to Italian CRO Cromsource.

CROs moving away from strategic partnerships? Survey investigates

16-Apr-2014 - As larger partnerships between CROs and sponsors come to maturity, a new survey found that “a much greater proportion of CRO revenue growth” will come from small and medium-sized pharma...

CRO industry sees salary budgets increase across the board, survey finds

15-Apr-2014 - A recent study found that CRO employees are seeing rapid budget increases for salaries across the globe, with an average increase of about 4% for 2014.

TransCelerate recognizes training programs from Icon, Synteract

15-Apr-2014 - Industry group TransCelerate Biopharma has certified that training programs from CROs Icon and SynteractHCR meet minimum criteria for ICH’s good clinical practice (GCP) training.

CROs to 'push' patients into trials using partners, report predicts

14-Apr-2014 - Patient recruitment is “the major bottleneck” in clinical development, an Industry Standard Research report says, but though it predicts a drive to ‘push’ patients into trials, industry disagrees.

News in brief

Karyopharm Therapeutics selects CRO Clinipace as preferred provider

14-Apr-2014 - Karyopharm Therapeutics has selected CRO Clinipace to help discover first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, 

CROs to profit from large slice of $91bn biotech pie, say analysts

10-Apr-2014 - Much of the $91bn (€66bn) raised in biotech capital over the last twelve months will end up in the hands of the CRO industry, according to a survey from analyst...

Alliance with patient network won't replace CRO partnerships, says Genentech

09-Apr-2014 - Genentech says its collaboration with PatientsLikeMe will enable more effective clinical trial recruitment but will not affect its partnerships with CROs.

UK clinical research network restructures as trial numbers climb

09-Apr-2014 - The National Institute for Health Research (NIHR) Clinical Research Network, which provides more than £284m ($475m) a year to support the delivery of clinical research studies, has reconfigured to become...

EU law: public database for trial transparency

08-Apr-2014 - Companies running clinical trials will have to use an online portal to stay on the right side of the latest EU legislation on data transparency.

Survey: Supply chain execs to up clinical trial logistics spend

07-Apr-2014 - Almost two-thirds of supply chain executives plan to increase their expenditure in clinical trial logistics over the next two years, according to an industry survey conducted by Marken.

Mid-size CROs see uptick in clinical trial wins

07-Apr-2014 - As smaller biotech, pharma and medical device companies seem keen to expand R&D, they also seem to be consistently turning to mid-size CROs to run their trials.

All clinical trials to be published under European law

03-Apr-2014 - Pharmaceutical companies will be made to publish all European clinical trials in a public database under a draft law passed by the European Parliament yesterday.

Always on my mind or return to vendor? CRO models discussed in Vegas

03-Apr-2014 - Big Pharma's split opinion on the best way to work with a CRO was in evidence in Las Vegas this week with Pfizer underlining its commitment to strategic deals and...

BioClinica inks $30m in contract extensions with two top pharmas

02-Apr-2014 - CRO BioClinica has signed two multi-year contract extensions worth $30m for cloud-based technologies and professional services and training across its e-clinical product suite.

CROs further consolidate: Icon scoops up Aptiv for $144M

01-Apr-2014 - Ireland-based CRO Icon has agreed, subject to certain closing conditions, to acquire Aptiv Solutions for $143.5m in cash to further expand its adaptive trial offerings. 

CROs debate: Can surrogate endpoints speed oncology drugs to market?

31-Mar-2014 - As biopharma companies look to develop cancer therapies more quickly, some are turning to CROs with the hopes of using surrogate endpoints to expedite US FDA approval.

Parexel opens Singapore clinical trial supply centre

19-Mar-2014 - Parexel has enlarged its clinical trial supply network with the opening of a distribution centre in Singapore and expansion of its Massachusetts facilities.  

Parexel joins cloud-based community of life science companies

13-Mar-2014 - Cloud-based community provider Exostar has selected Parexel as the latest CRO to become a member of its life science community, which aims to reduce the cost and burdens of collaborations...

Exclusive interview

CRO Clinipace moves into Asia with acquisition of Choice Pharma

11-Mar-2014 - Clinipace Worldwide announced today that it will acquire Choice Pharma, a pan-Asian CRO.

Quintiles talks R&D spend and outsourcing trend in Second Public Offering

10-Mar-2014 - Nearly 40% of the $51bn spent on clinical development last year was outsourced according to Quintiles, which has predicted continued growth for the CRO industry in documents outlining its second...

Exclusive interview

INC Research expands into Middle East with MEK acquisition

10-Mar-2014 - In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.

Exclusive interview

Celerion expands into South Korea, CEO talks strategy with

06-Mar-2014 - Susan Thornton PhD, president and CEO of Celerion, broke down the company’s recent moves to partner with Seoul National University Hospital in an exclusive.

CRO KCR expands further into Western Europe

05-Mar-2014 - European CRO KCR has registered two new entities in the UK and Germany, which adds to its presence in 18 countries in Europe as well as the US. 

Demand for labs that can handle deadly viruses is catching says TNO

03-Mar-2014 - Scientists developing vaccines for potentially deadly diseases like influenza, SARS and HIV struggle to find a CRO with the right capabilities according to contractor TNO Triskelion.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing